These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Correlations of human herpesvirus 6B and CMV infection with acute GVHD in recipients of allogeneic haematopoietic stem cell transplantation. Wang LR, Dong LJ, Zhang MJ, Lu DP. Bone Marrow Transplant; 2008 Nov; 42(10):673-7. PubMed ID: 18695666 [Abstract] [Full Text] [Related]
11. Cytomegalovirus infections in allogeneic stem cell recipients after reduced-intensity or myeloablative conditioning assessed by quantitative PCR and pp65-antigenemia. Schetelig J, Oswald O, Steuer N, Radonic A, Thulke S, Held TK, Oertel J, Nitsche A, Siegert W. Bone Marrow Transplant; 2003 Oct; 32(7):695-701. PubMed ID: 13130317 [Abstract] [Full Text] [Related]
12. Interferon gamma 13-CA-repeat homozygous genotype and a low proportion of CD4(+) lymphocytes are independent risk factors for cytomegalovirus reactivation with a high number of copies in hematopoietic stem cell transplantation recipients. Jaskula E, Dlubek D, Duda D, Bogunia-Kubik K, Mlynarczewska A, Lange A. Biol Blood Marrow Transplant; 2009 Oct; 15(10):1296-305. PubMed ID: 19747638 [Abstract] [Full Text] [Related]
13. Cytomegalovirus shedding in the oral cavity of allogeneic haematopoietic stem cell transplant patients. Correia-Silva Jde F, Victória JM, Guimarães AL, Salomão UE, de Abreu MH, Bittencourt H, Gomez RS. Oral Dis; 2007 Mar; 13(2):163-9. PubMed ID: 17305617 [Abstract] [Full Text] [Related]
14. A randomized trial of high dose polyvalent intravenous immunoglobulin (HDIgG) vs. Cytomegalovirus (CMV) hyperimmune IgG in allogeneic hemopoietic stem cell transplants (HSCT). Zikos P, Van Lint MT, Lamparelli T, Gualandi F, Occhini D, Mordini N, Berisso G, Bregante S, Bacigalupo A. Haematologica; 1998 Feb; 83(2):132-7. PubMed ID: 9549924 [Abstract] [Full Text] [Related]
16. Fludarabine-based reduced intensity conditioning transplants have a higher incidence of cytomegalovirus reactivation compared with myeloablative transplants. George B, Kerridge I, Gilroy N, Huang G, Hertzberg M, Gottlieb D, Bradstock K. Bone Marrow Transplant; 2010 May; 45(5):849-55. PubMed ID: 19915635 [Abstract] [Full Text] [Related]
17. Incidence of Viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients. Satwani P, Baldinger L, Freedman J, Jacobson JS, Guerra J, van de Ven C, Morris E, Garvin J, George D, Bradley MB, Bhatia M, Tallamy B, Schwartz J, Jin Z, Cairo MS. Biol Blood Marrow Transplant; 2009 Dec; 15(12):1587-95. PubMed ID: 19896083 [Abstract] [Full Text] [Related]
18. Cytomegalovirus infection in children who underwent hematopoietic stem cell transplantation at a single center: a retrospective study of the risk factors. Yoon HS, Lee JH, Choi ES, Seo JJ, Moon HN, Kim MN, Im HJ. Pediatr Transplant; 2009 Nov; 13(7):898-905. PubMed ID: 19032414 [Abstract] [Full Text] [Related]
19. L-index as a novel index to evaluate both the intensity and duration of lymphopenia after allogeneic hematopoietic stem cell transplantation. Kimura SI, Wada H, Sakamoto K, Ashizawa M, Sato M, Terasako K, Nakasone H, Kikuchi M, Okuda S, Kako S, Yamazaki R, Oshima K, Tanaka Y, Tanihara A, Nishida J, Kanda Y. Transpl Infect Dis; 2012 Aug; 14(4):364-73. PubMed ID: 22469427 [Abstract] [Full Text] [Related]
20. Cytomegalovirus infections following umbilical cord blood transplantation using reduced intensity conditioning regimens for adult patients. Matsumura T, Narimatsu H, Kami M, Yuji K, Kusumi E, Hori A, Murashige N, Tanaka Y, Masuoka K, Wake A, Miyakoshi S, Kanda Y, Taniguchi S. Biol Blood Marrow Transplant; 2007 May; 13(5):577-83. PubMed ID: 17448917 [Abstract] [Full Text] [Related] Page: [Next] [New Search]